NanoMab Technology Limited is a privately held biopharmaceutical company in the development of next generation cancer precision medicine. We are developing medicine for fast and specific delivery of radiation to treat cancer. A therapeutic product is made by a camelid antibody labelled with a radioisotope of therapeutic radiation. This therapeutic product is paired with a diagnosis, using the same antibody vector but labelled with a lower radiation radioisotope for imaging. Our goal is to develop a pipeline of therapeutic and diagnostic pairs, using our proprietary platform of camelid antibodies and of labelling radioisotopes onto the antibodies.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 成都北路333號, 上海,上海,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://WWW.NANO-MAB.COM
- HQ
- 上海, 上海
Nanomab Questions
Nanomab's website is http://WWW.NANO-MAB.COM
Nanomab's LinkedIn profile is https://cn.linkedin.com/company/nanomab
Nanomab has
6 employees.
View email and phone details for 6
employees at Nanomab.
Nanomab's industry is
Pharmaceutical Manufacturing
Nanomab's top competitors are
Sofie,
Theragnostics,
Convergent Therapeutics, Inc.,
Artbio,
Blue Earth Therapeutics,
Applied Molecular Therapies,
Rls Radiopharmacies,
Full-Life Technologies,
Nucleus Radiopharma,
Radiomedix, Inc..
Nanomab's categories are Pharmaceutical Manufacturing
Nanomab's founding year is 2016
